Abstract:AIM: To investigate if non-alcoholic fatty liver disease (NAFLD) is an early mediator for prediction of metabolic syndrome, and if liver B-ultrasound can be used for its diagnosis.METHODS: We classified 861 obese children (6-16 years old) into three subgroups: group 0 (normal liver in ultrasound and normal transaminases); group 1 (fatty liver in ultrasound and normal transaminases); and group 2 (fatty liver in ultrasound and elevated transaminases). We measured the body mass index, waist and hip circumference, blood pressure, fasting blood glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), whole-body insulin sensitivity index (WBISI), lipid profile and transaminases in all the participants. The risk of developing metabolic syndrome (MS) was assessed according to the degree of liver fatty infiltration based on the B-ultrasound examination.RESULTS: Among the 861 obese children, 587 (68.18%) were classified as having NAFLD, and 221 (25.67%) as having MS. The prevalence of MS in NAFLD children (groups 1 and 2) was 37.64% (221/587), which was much higher than that in non-NAFLD group (group 0, 12.04%) (P < 0.01). There were significantly higher incidences concerning every component of MS in group 2 compared with group 0 (P < 0.05). The incidence of NAFLD in MS patients was 84.61% (187/221), which was significantly higher than that of hypertension (57.46%, 127/221) and glucose metabolic anomalies (22.62%, 50/221), and almost equal to the prevalence of dyslipidemia (89.14%, 197/221). Based on the B-ultrasound scales, the presence of moderate and severe liver fatty infiltration carried a high risk of hypertension [odds ratio (OR): 2.18, 95% confidence interval (95% CI): 1.27-3.75], dyslipidemia (OR: 7.99, 95% CI: 4.34-14.73), impaired fasting glucose (OR: 3.65, 95% CI: 1.04-12.85), and whole MS (OR: 3.77; 95% CI: 1.90-7.47, P < 0.01). The state of insulin resistance (calculated by HOMA-IR and WBISI) deteriorated as the degree of fatty infiltration increased.CONCLUSION: NAFLD is not only a liver disease, but also an early mediator that reflects metabolic disorder, and liver B-ultrasound can be a useful tool for MS screening. (C) 2011 Baishideng. All rights reserved.

Clinical Analysis of 162 Cases of Non-alcoholic Fatty Liver Disease

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

[The Association Between Body Mass Index and Non-Alcoholic Fatty Liver Disease].

Non-alcoholic Fatty Liver Disease: an Early Mediator Predicting Metabolic Syndrome in Obese Children?

Clinical and Pathological Analysis of 86 Patients with Nonalcoholic Fatty Liver

Analysis of related risk factors of nonalcoholic fatty liver disease

Association of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes: Clinical Features and Independent Risk Factors in Diabetic Fatty Liver Patients.

Study on the Relationship between Phospholipids and Nonalcoholic Fatty Liver Disease

Clinicopathological analysis of non-alcoholic steatohepatitis

General Characteristics and Clinical Practices of Chinese Patients with Non-Alcoholic Fatty Liver Disease

The Clinical Analysis of Non-alcoholic Fatty Liver Disease among Schizophrenia lnpatients

Relationship Between Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.

Epidemiologic and Clinical Analysis of Non-viral Liver Diseases

Clinical characters and risk factors of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

CLINICAL PROFILE WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME PATIENTS

Clinical Characteristics of Coronary Artery Disease in Patients with Nonalcoholic Fatty Liver Disease

Clinical Analysis of 267 Patients with Fatty Liver and Blood Fat and Blood Glucose

A Clinical and Pathological Study of Nonalcoholic Fatty Liver Disease

The Clinical Study on Nonalcoholic Fatty Liver Disease in 121 Patients

Analysis of the clinical features and complications of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus

Ciinicopathological analysis of fatty liver